Company intelligence / Profile preview

Maypharm

Seoul, South Korea

Ownership: Private
Employees: ~52
Development stage: Other

Overview

Maypharm is a global leader in the cosmetic medicine and dermaceuticals market, offering a broad portfolio of commercialized products such as dermal fillers, botulinum toxin, anesthetics, and skin cosmetics, manufactured to international quality certifications. There are no clinical-stage drugs; all are marketed products.

Therapeutic areas: DermatologyOther
Modalities: Medical deviceBiologicSmall moleculeDermal fillerBotulinum toxin
Industry: Biotech

Partnerships

Strong global partnerships for distribution and market entryCollaboration with Zalika Group (Brazil) for LATAM distribution

Beyond the preview

Go deeper on Maypharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maypharm.

Explore the full profile